key: cord-0682865-cg3ebmhq
authors: Antonino, Cannavò; Serena Maria, Passamonti; Daniela, Martinuzzi; Antonio, Longobardi; Andrea, Fiorattini; Nicoletta Margherita, Troni; Helena, Esposito Martha; Nicolina, Dell’Orefice; Rosanna, Torelli; Tullia Maria, De Feo
title: THE IMPACT OF COVID-19 ON SOLID ORGAN DONATION: The North Italy Transplantation program (NITp) EXPERIENCE
date: 2020-06-25
journal: Transplant Proc
DOI: 10.1016/j.transproceed.2020.06.025
sha: 986c79fbc493a16e7bdec44681ebf514dd1b428c
doc_id: 682865
cord_uid: cg3ebmhq

Introduction coronavirus disease 2019 (COVID-19) outbreak has unfavourably influenced the overall donation activity. Aim the aim of this study was to investigate effect of COVID-19 on transplantation in the North Italy Transplant program (NITp). Material and methods this was a cross-sectional study in which all consecutive potential deceased donors proposed in the NITp during 6 weeks from February 21, 2020 (period A) were included and compared to all potential donors during the same time frame of the previous years (period B) and all potential donors during six weeks before February 20, 2020 (period C). Results fifty-eight deceased donors were proposed during period A, 95 during Period B and 128 Period C. After evaluation process 32/58 (55.2%), 60/95 (63.2%) and 79/128 (61.7%) donors were used for organ donation in period A, B and C, respectively (p-value 0.595). Results: this study showed an important reduction of donations and transplants during the COVID-19 pandemic. A strict monitoring should be mandatory to ensure a safety procedure.

15.362 (12.3%) dead [3] . The Northern Italian regions were mostly affected, and this dramatic scenario changed the physiognomy of hospitals that became COVID-19 centers with a burden impact on health and economy system [4] . The initial experience of the COVID-19 outbreak shows that around 3-4% of infected patients need intensive care management to overcome the acute respiratory distress syndrome. Transplantation is the treatment of choice for several end-stage diseases. Due to the high numbers of infected patients, the risk of saturation of the intensive care units (ICU) with the unavailability for both donors and organs recipients appears real and may unfavourably influence the overall donation activity [5] .

With this background, we investigated the effect of COVID-19 on solid organ transplantation system from donors referred to the North Italy Transplant program (NITp).

This is a cross-sectional study in which all consecutive potential deceased donors proposed by any NITp ICUs during the 6 weeks from February 21, 2020 (period A) were included and compared to all potential donors during the same time frame of 2019 (6 weeks from February 21, 2019period B) and during the 6 weeks before February 20, 2020 (period C). The 3 periods were compared to investigate any change in total number of potential and eligible donations, donors' procurement and total transplants by solid organ and priority reason for assignment. Living and extra-NITp regions donors were excluded.

NITp is a transplantation program involving six Italian regions including Lombardy, Veneto, Friuli Venezia Giulia, Liguria, Marche and Provincia Autonoma di Trento (P.A. Trento). The ICUs usually report the presence of any potential donor to the operative reference center that evaluates clinical data and establishes a risk profile as standard, non-standard or unacceptable, according to Centro Nazionale Trapianti (CNT) guidelines [6].

General and clinical donors' characteristics, organs allocation and recovery were collected for each donor. Organ allocation was classified in urgent or not urgent according to recipients' status at the moment of transplantation.

All consecutive deceased donors referred from February 20, 2020 were tested for SARS-CoV-2 real-time reverse transcription PCR (RT-PCR). At the beginning of the COVID-19 outbreak, CNT recommended nasopharyngeal swab and bronchoalveolar lavage (BAL) might be used as alternative in all potential donors. Subsequently, BAL became mandatory and performed the day of procurement or within 24 hours before the recovery. In all cases the test result had to be available before the recovery [7] . All these procedures were performed to ensure safety for all recipients to avoid donor-related infection transmission.

Descriptive analyses were performed. Continuous variables were expressed as mean values and standard deviation (SD) and compared using the two-tailed Student's t-test and Kruskal-Wallis test where appropriate. A p-value < 0.05 was considered statistically significant. Categorical variables were expressed as frequencies and percentage values and compared by X 2 test. Statistical analyses were performed with SPSS, version 23.0 (IBM Corp., Armonk, NY).

From February 21 to April 03, 2020 a total of 58 deceased donors were proposed, i.e., 2 (3.4%) in Liguria, 25 (43.1%) in Lombardy, 20 (34.5%) in Veneto, 4 (6.9%) in Friuli, 2 (3.4%) in P. A. Trento, and 5 (8.6%) in Marche.

Ninety-five donors were evaluated during the same time frame during 2019 (period B) and 128 during the six weeks before February 20, 2020 (period C).

During period A, 26 donors (45%) were excluded, mainly due to objection for organ donation (17/26, 65.4%), unacceptable risk (6/26, 23%) of whom the half (3/6) for the presence of an active cancer, or COVID-19 positive BAL (3/6). Organs from 3 (11.5%) potential donors were considered unsuitable for donation during clinical evaluation and/or surgical procedures. We did not observe any difference in terms of consent rate or any other reason for excluding donors across the three periods (p-value= 0.956).

After evaluation process, 32/58 (55.2%), 60/95 (63.2%) and 79/128 (61.7%) donors were used in period A, B and C, respectively (p-value 0.595). No differences were found in used donors' proportion across the regions by the considered time frames (p-value 0.902) ( Table 1) .

During the period A, the mean donors' age was 60 years (SD±14.4), and female sex was prevalent (19/32, 59.4%). Brain hemorrhage and post-anoxic injuries were the main causes for hospitalization, 17 (53.1%) and 10 (31.3%), respectively. More than a half (20/32, 63%) had a standard risk profile, whereas no-standard risk profile was attributed to the remaining 37% (12/32) of donors. No differences were found in age (p-value = 0.844), sex (p-value = 0.196), cause of hospitalization (p-value = 0.682) and risk profile (p-value = 0.316) distribution among the 3 periods. Furthermore, no difference was observed between AB0 group distribution (p-value 0.864) ( Table 1) .

During period A, a 39% reduction of total deceased donation rate was compared to period B, was observed and a 55% reduction compared to period C. Considering used donors, the reduction was 47% and 60%, respectively. Compared to period B the highest reductions were observed in Liguria and Veneto (75% and 68%, respectively), and the lowest in Lombardy e Marche (23% and 25%, respectively). The reduction is higher when period C was considered, 75% in Liguria, 51% in Lombardy, 78% in Veneto, 50% in Friuli, 33% in P.A. Trento and 25% in Marche ( Figure 1C ).

During period A, 95 solid organ transplants were performed, i.e., 54 kidney, 32 liver (including 2 left split-livers), 3 lung and 6 heart transplants. Urgent liver, heart and lung transplants were 5/32 (16%), 0 (0), and 3/6 (50%), respectively. Globally a 44% and 59% reduction of total solid organ transplantation rate was observed compared to period B and period C, respectively.

In details, in heart transplantation a reduction of 57% and 65% compared to period B and C, respectively, was observed; in lung transplantation the reduction was 67% compared to both periods, in liver transplantation 38% and 57%, respectively, in kidney transplantation 43% and 60%, respectively ( Figure 2 ).

No differences were observed in single organ discharge rate and reason for discharging across the 3 periods (p-value > 0.05) with the exclusion of lung discharge reason (p-value 0.01) ( Table 2 ).

Our study shows that during the first 6 weeks of COVID-19 outbreak there was an important reduction of potential donors and solid organ transplantation compared to the same period in 2019 in the regions referred to the NITp. This decrease is even higher when the 6 weeks before February 20, 2020 were considered. As expected, the trend of reduction was higher in the most highly affected regions.

Transplantation is the treatment of choice for several end-stage diseases, but during the COVID-19 spread the lower number of potential donors and the ICUs beds availability limited the access to this treatment. Our study observed a more severe reduction of organs donations compared to a previous paper [5] . This difference reflects the dramatically higher spread in the NITp regions then in rest of Italy.

Despite the Transplantation Society recommended to consider the temporary suspension of both deceased and living-related donors [8] , transplant activities continued in the NITp area, satisfying not only the emergency list (8 transplants), but also the standard list. Our experience shows the utility and the importance of continuing donation and transplant process if procurement and transplant procedures follow a COVID-19 free pathway for both donors and recipients.

Besides the limited donors' number, a potential donor-related COVID-19 transmission could have been a risk for transplanted patients, thus an extensive donors' COVID-19 testing has been considered mandatory from the beginning [6]. We conducted a survey of patients transplanted after February 21 and we found that 5 patients developed COVID-19 after more than 10 days from transplantation. All these patients were transplanted from different donors, and no other recipients transplanted with an organ from these 5 donors developed the infection. Furthermore, we found a significantly lower incidence of COVID-19-related diseases in transplanted recipients compared to recently published papers where previously transplanted patients and/or waiting list patients were included [9] [10] [11] . In line with a previous paper [12] , those data may support the hypothesis that the COVID-19 transmission should be considered not donor-related and the extensive procedure of testing guaranteed a safe transplantation.

The main limitation of this study was the limited extension of transplanted follow-up to assess the actual incidence of post-transplant COVID-19 infection. This was not the aim of this paper, but the follow-up was long enough to be confident in excluding a donor-related transmission.

In conclusion, Italy has been one of the first countries dealing with the spread of COVID-19. This dramatic scenario changed the physiognomy of our hospitals with a negative impact on the management of donation process. On the other hand, we did not find any absolute concern in the safety of solid organ transplantation. The BAL monitoring seemed to be safe in preventing COVID-19 donor-related transmission. However, the need of shifting resources from transplantation to COVID-19 emergency and the risk of hospital-related transmission inevitably raise questions regarding the selection of recipients. The figure plotted numbers of total transplants by solid organs during the 3 considered periods: period A (6 weeks after February 21, 2020 included), period B (6 weeks after February 21, 2019 included) and period C (6 weeks before February 20, 2020 included). *Spontaneous cerebrovascular events were classified as brain hemorrhages. Traumatic events were classified as trauma 

Epidemiology of Covid-19

World Health Organization. Novel Coronavirus (COVID-19) situation

Italian National Institute of Health

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs

Italian National Transplant Centre. Information for transplant programs regarding novel Coronavirus

An update and guidance on 2019 novel coronavirus (2019-nCov) pretransplant ID clinicians

A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia

Brescia Renal COVID Task Force . Management of patients on dialysis and with kidney transplant during SARS-COV-2 (COVID-19

Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center

How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic. A sound transplant protection strategy